Cabaletta Bio Inc (CABA)

Dec 10, 2025

CABA Receives FDA Orphan Status for Myasthenia Gravis Treatment - GuruFocus

Dec 10, 2025

Dec 09, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 09, 2025

Dec 07, 2025

Weekly Earnings: Will Cabaletta Bio Inc stock recover faster than marketMarket Sentiment Report & Technical Pattern Based Buy Signals - BỘ NỘI VỤ

Dec 07, 2025

Dec 06, 2025

Cabaletta Bio (CABA) Price Target Increased by 15.31% to 14.41 - Nasdaq

Dec 06, 2025

Dec 03, 2025

Cabaletta Bio (CABA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 01, 2025

Evercore Healthcare Conference - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Is Cabaletta Bio Inc stock gaining market shareWeekly Trading Summary & Low Risk High Win Rate Picks - BỘ NỘI VỤ

Dec 01, 2025

Nov 30, 2025

Cabaletta Bio Prices Public Offering to Raise $100 Million - MSN

Nov 30, 2025

Nov 30, 2025

Cabaletta Bio Advances Rese-cel Pipeline as BLA Submission for Myositis Nears - MSN

Nov 30, 2025

Nov 28, 2025

Form 8-KCurrent report - ADVFN

Nov 28, 2025

Nov 27, 2025

Jefferies Financial Group Inc. Takes $3.04 Million Position in Cabaletta Bio, Inc. $CABA - MarketBeat

Nov 27, 2025

Nov 21, 2025

Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences - MSN

Nov 21, 2025

Nov 19, 2025

How supply chain issues affect Cabaletta Bio Inc. stock2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com

Nov 19, 2025

Nov 19, 2025

Can Cabaletta Bio Inc. stock maintain operating margins2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com

Nov 19, 2025

Nov 19, 2025

Will Cabaletta Bio Inc. stock outperform Nasdaq indexQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com

Nov 19, 2025

Nov 19, 2025

How Cabaletta Bio Inc. stock reacts to oil pricesJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

How Cabaletta Bio Inc. stock performs in rising dollar environmentTrade Risk Assessment & Weekly High Momentum Picks - newser.com

Nov 19, 2025

Nov 18, 2025

CABALETTA BIO INC (CABA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 18, 2025

Nov 18, 2025

Why Cabaletta Bio Inc. stock could rally in 2025Bond Market & AI Based Buy/Sell Signal Reports - newser.com

Nov 18, 2025

Nov 18, 2025

Cabaletta Bio’s Bold Autoimmune Push Raises Big Questions About the Future of CAR T - MyChesCo

Nov 18, 2025

Nov 17, 2025

Tools to assess Cabaletta Bio Inc.’s risk profileJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com

Nov 17, 2025

Nov 17, 2025

Is Cabaletta Bio Inc. stock attractive for ETFsLong Setup & Weekly Return Optimization Plans - newser.com

Nov 17, 2025

Nov 16, 2025

Will Cabaletta Bio Inc. see short term momentumLong Setup & Real-Time Stock Entry Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

How Cabaletta Bio Inc. stock reacts to bond yieldsChart Signals & Verified Short-Term Plans - newser.com

Nov 16, 2025

Nov 15, 2025

Visualizing Cabaletta Bio Inc. stock with heatmapsRate Cut & Fast Entry High Yield Tips - newser.com

Nov 15, 2025

Nov 15, 2025

What technical signals suggest for Cabaletta Bio Inc. stock2025 Dividend Review & Weekly Top Gainers Alerts - newser.com

Nov 15, 2025

Nov 14, 2025

Is Cabaletta Bio Inc. stock a contrarian buy2025 Trading Volume Trends & Safe Capital Investment Plans - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

Cabaletta Bio Advances in Autoimmune Therapy Development - MSN

Nov 14, 2025

Nov 14, 2025

Cabaletta Bio FY2025 EPS Estimate Increased by William Blair - MarketBeat

Nov 14, 2025

Nov 13, 2025

Advanced analytics toolkit walkthrough for Cabaletta Bio Inc.July 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com

Nov 13, 2025

Nov 12, 2025

Cabaletta Bio (CABA) Gets a Buy from H.C. Wainwright - The Globe and Mail

Nov 12, 2025

Nov 11, 2025

Cabaletta Bio Draws Analyst Praise Despite Growing Losses - Finimize

Nov 11, 2025